Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
DRC Ebola Outbreak Poses Unique Challenges: Limited Treatments, Remote Location, Cultural Barriers
A Bundibugyo Ebola outbreak in remote eastern DRC presents significant challenges due to lack of medical countermeasures, geographic isolation, and community d…
HighCDC Backs Extra COVID Vaccine Dose for Immunocompromised Americans
CDC and FDA have authorized a third COVID-19 vaccine dose for immunocompromised Americans, who represent 40-44% of breakthrough cases despite full vaccination.
HighRare Kidney Cancer Shows Promise With Immunotherapy, Demands Research Equity
A systematic review on immunotherapy for Bellini's collecting duct carcinoma reveals promising treatment signals, highlighting the urgent need for coordinated…
HighUpdated COVID vaccines show 48% effectiveness against dominant XBB variants
CDC data confirms updated COVID-19 boosters prevent roughly half of symptomatic infections from dominant XBB variants, with effectiveness declining in older ad…
HighIsrael treats suspected first Ebola case as DRC outbreak spreads
Israel is treating a suspected Ebola patient at Haifa hospital following travel to the DRC, where a Bundibugyo strain outbreak has killed over 200. Confirmatio…
HighPfizer/BioNTech vaccine shows 91% efficacy in updated trial, protects against South African variant
Pfizer/BioNTech's COVID-19 vaccine shows 91% efficacy in updated trial data covering six months of follow-up, with early evidence of protection against the Sou…
HighGLP-1 drugs show potential cancer benefits across multiple tumor types, studies suggest
Multiple studies presented at ASCO suggest GLP-1 drugs like Ozempic reduce cancer risk, metastasis, and improve survival across tumor types, though randomized…
MediumGurugram hospital launches India's first myeloma and lymphoma centre of excellence
Fortis Memorial Research Institute in Gurugram launched India's first Centre of Excellence for Myeloma & Lymphoma, integrating multidisciplinary expertise, pre…
HighModerna's personalized mRNA melanoma vaccine shows promise in preventing cancer recurrence
Moderna's personalized mRNA melanoma vaccine demonstrated significant efficacy in Phase 3 trials, helping advanced-stage patients remain cancer-free longer whe…
HighStudy: Younger Black Americans Face Alarming Rise in Heart Disease Risk Factors
A study of hospitalized Black Americans aged 18-44 found sharp increases in obesity, diabetes, and smoking from 2007-2017, with significantly worse heart healt…
HighmRNA COVID Vaccines Show Survival Boost in Advanced Cancer Patients
Cancer patients receiving mRNA COVID vaccines demonstrated significantly improved survival rates, with advanced lung cancer patients showing 37.33 months media…
HighOral relaxin agonist AZD5462 shows promise in heart failure treatment
AZD5462, an oral relaxin agonist, improved cardiac function in chronic heart failure patients in the LUMINARA trial, with benefits greatest at the lowest dose…
HighDoctors Debunk 7 Dangerous Health Myths Indians Still Believe
On National Doctor's Day 2026, Indian medical experts identify seven widespread health myths causing serious harm, from antibiotic misuse to vaccine hesitancy,…
HighThree vaccine candidates fast-tracked for rare Bundibugyo Ebola strain with no approved treatment
East Africa's Bundibugyo Ebola outbreak has triggered urgent development of three vaccine candidates and potential treatments, as no approved vaccines exist fo…
HighFDA poised to approve scaled COVID vaccine for children ages 5-11
The FDA and CDC are expected to approve a scaled-down Pfizer-BioNTech COVID vaccine for children ages 5-11 by early November, with rollout through 25,000 pedia…
HighLecanemab for Alzheimer's: Modest Benefits Demand Careful Patient Discussions
Canada approved lecanemab for early Alzheimer's disease, but experts warn clinical benefits are modest while serious risks and high costs require careful patie…
HighCDC warns Congo Ebola outbreak could exceed West Africa crisis without urgent containment
CDC warns that weak containment of the Bundibugyo Ebola outbreak in Congo and Uganda could produce a crisis exceeding the 2014-2016 West Africa epidemic's 11,0…
HighMaternal RSV vaccine cuts infant hospitalizations by 70%, real-world study confirms
A University of Pittsburgh study published in JAMA Network Open found that maternal RSV vaccination during pregnancy reduces hospitalization risk in infants un…
HighKidney drug finerenone shows promise for millions beyond diabetes patients
Three major clinical trials show finerenone protects kidney and heart function in millions with chronic kidney disease, including non-diabetic patients with li…
HighAmerican doctor in Congo confirmed with Ebola, transferred to Germany for treatment
An American missionary doctor in the Democratic Republic of Congo tested positive for Ebola and is being treated in Germany. The outbreak, involving a rare Bun…
HighNovo Nordisk Expands Weight-Loss Drug Trials to Obesity-Linked Conditions
Novo Nordisk plans clinical trials to test weight-loss drugs like Wegovy for treating obesity-linked conditions including osteoarthritis and sleep apnea, while…
HighDR Congo launches trial of experimental Ebola prevention drug amid outbreak
Over 250 people in eastern DR Congo have enrolled in a clinical trial testing obeldesivir, an experimental antiviral drug designed to prevent Ebola after expos…
HighResearchers call for clinical trials of Paxlovid for long COVID
UCSF researchers present case studies of long COVID patients who experienced symptom relief after Paxlovid treatment, calling for formal clinical trials to tes…
HighViral Hantavirus Treatment Video Actually Shows COVID-19 Care from 2020
A viral video falsely claiming to show Hantavirus patient treatment is actually 2020 COVID-19 footage from Italy. Fact-checkers used reverse image search to id…
HighGlobal health agencies race to contain Ebola outbreak as vaccine funding accelerates
Multiple health crises dominate global headlines: Ebola outbreak in DRC spreads to Uganda with 321 confirmed cases, while $60M funding accelerates vaccine deve…
HighTreasury Warns of Surging Covid-19 Vaccine Scams and Ransomware Threats
The U.S. Treasury Department warned of rising cyberattacks and scams targeting COVID-19 vaccination efforts, with ransomware and counterfeit vaccines posing si…
HighExperimental pancreatic cancer drug daraxonrasib doubles survival in landmark trial
Experimental drug daraxonrasib nearly doubled survival rates for advanced pancreatic cancer patients in phase 3 trials, with median survival jumping from 6.7 t…
HighDR Congo Ebola Cases Pass 10,000 as Bundibugyo Outbreak Spreads Abroad Without Approved Vaccine
DR Congo has reported 10,060 Ebola cases and 4,887 deaths from the Bundibugyo virus, which has no approved vaccine or specific treatment. Cases have spread to…
HighResearchers identify new Ebola variant, propose repurposed drug treatment
Researchers at Dalhousie University helped identify a new Bundibugyo ebolavirus variant in Uganda and DRC, publishing studies on the virus's genetics and a pot…
HighRetatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Reshape Metabolic Medicine
Retatrutide, Eli Lilly's investigational triple-hormone receptor drug, shows promise as a next-generation weight-loss treatment with potential longevity benefi…
HighGreater Weight Loss From GLP-1 Drugs Significantly Reduces Obesity-Related Complications
Real-world study of 89,718 GLP-1 drug users shows greater weight loss correlates with significantly lower risk of obesity-related conditions including osteoart…
HighDRC launches record-pace Ebola drug trial as first patients enrolled
DRC launches unprecedented clinical trial for Ebola treatment just six weeks after outbreak declaration, testing two experimental drugs on patients in Ituri re…
HighGlobal health agencies mobilize against mpox, COVID variants amid bird flu spread
Multiple countries launch coordinated vaccination efforts against mpox, COVID-19, and polio while managing emerging threats like bird flu and Oropouche virus o…
HighFDA Clears Third COVID Vaccine Dose for Immunocompromised Americans
The FDA authorized a third COVID-19 vaccine dose for immunocompromised Americans, including transplant recipients, after months of pressure from high-risk pati…
HighWHO warns cancer kills 26,000 daily as Nigeria expands patient support
WHO reports 10 million annual cancer deaths globally with projections rising to 35 million by 2050. Nigeria expands financial support and local drug production…
HighMachine Learning System Personalizes Clinical Test Recommendations for Individual Patients
Researchers developed iCARE, a machine-learning framework that recommends personalized clinical tests for individual patients rather than using one-size-fits-a…
HighChina launches first AI-powered personalized cancer vaccine production line
China's Likang Life Sciences is opening its first AI-assisted personalized tumor vaccine production line in Beijing, using genetic analysis to identify patient…
HighRare Bundibugyo Ebola strain spreads undetected in Congo, triggering global health emergency
A rare Bundibugyo Ebola strain outbreak in Congo's Ituri province went undetected for four weeks before confirmation on May 14, with 59 hospitalizations and no…
HighEU safety committee reviews reports of menstrual changes after mRNA COVID vaccines
European Medicines Agency's safety committee is investigating reports of menstrual bleeding changes in women who received Pfizer/BioNTech or Moderna COVID-19 v…
HighNigeria Confirms First Ebola Case as Rare Bundibugyo Strain Spreads Across Africa
Nigeria has confirmed its first Ebola case in a woman who traveled from Uganda to Abuja, with authorities identifying 44 contacts for tracing as the Bundibugyo…
HighNigeria confirms first Ebola case linked to East Africa outbreak
Nigeria has confirmed its first Ebola case linked to the current East African outbreak, with a female patient who traveled from Uganda now isolated in Abuja. H…
HighGLP-1 drugs linked to lower breast cancer risk, but experts urge caution
A Penn Medicine study of 110,000 women found GLP-1 users had 30% lower breast cancer risk, but experts caution the benefit likely stems from improved metabolic…
High'Walking Ebola' strain's slow progression complicates Congo outbreak response
Congo's Bundibugyo Ebola outbreak progresses slowly, allowing infected people to spread the virus while remaining mobile. This slower disease course may enable…
HighOnce-weekly diabetes drug offers new hope for Philippines' 4M Type 2 patients
Novo Nordisk launches a once-weekly GLP-1 receptor agonist in the Philippines for type 2 diabetes treatment, offering improved blood sugar control and cardiova…
HighGSK's RSV vaccine Arexvy approved for high-risk adults aged 18-49 in Korea
South Korea's MFDS approved GSK's Arexvy RSV vaccine for high-risk adults aged 18-49, expanding access beyond older populations. The approval follows clinical…
HighKidney Drug Deal, GLP-1 Cancer Promise Drive Healthcare Momentum
Travere Therapeutics secures $1.14B kidney drug deal with Everest Medicines while GLP-1 drugs show promising cancer treatment potential. Bird flu threat recede…
MediumUS Aid Cuts Hamper Ebola Response in DRC, Aid Workers Say
US funding cuts to global health programs, USAID dismantling, and WHO withdrawal have weakened disease surveillance and response capacity during a deadly Ebola…
HighNIH Awards $6.9M to Advance Tau-Targeting Alzheimer's Drug Toward Clinical Trials
NIH awards $6.9M to advance CNDR-51997, a compound targeting tau pathology in Alzheimer's disease, toward FDA clinical trials after showing efficacy in mouse m…
HighExperimental drug shows early promise for treatment-resistant prostate cancer
A Phase 2 clinical trial found that opaganib, an experimental drug targeting lipid metabolism, showed modest but meaningful benefits when combined with standar…
HighNIH-developed Sudan virus vaccine shows complete protection in primate trials
NIH researchers successfully developed VSV-SUDV, an experimental vaccine based on the licensed Ebola vaccine, achieving complete protection against lethal Suda…
High